Home
Home

FDA

Apotex Is In The FDA Dog House, Again

Apotex Is In The FDA Dog House, Again
Pharmalot

Titan’s Probuphine Dosing May Need Review, FDA Staff Says

Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Bloomberg

FDA seeks to fast track Novartis lung cancer drug

FDA seeks to fast track Novartis lung cancer drug
Reuters

Navidea drops after FDA nod for drug used in cancer patients

Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech

FDA Head Of Generic Drugs Office Resigns

FDA Head Of Generic Drugs Office Resigns
Pharmalot

KV Pharma Goes After The FDA, Again

KV Pharma Goes After The FDA, Again
Pharmalot

Cempra: FDA alert on Zithromax will not affect us

Cempra: FDA alert on Zithromax will not affect us
Bizjournals.com

FDA wants to relax criteria for Alzheimer's drug approval, NY Times says

FDA wants to relax criteria for Alzheimer's drug approval, NY Times says
Yahoo/Fly on the Wall

FTC issues social-media ad rules. Will FDA finally be next?

FTC issues social-media ad rules. Will FDA finally be next?
Fierce Pharma

Biogen Idec says it filed for FDA approval of longer-lasting treatment for hemophilia A

Biogen Idec says it filed for FDA approval of longer-lasting treatment for hemophilia A
Yahoo/AP